tiprankstipranks
Trending News
More News >
Evolus Inc (EOLS)
NASDAQ:EOLS
US Market
Advertisement

Evolus (EOLS) Earnings Dates, Call Summary & Reports

Compare
553 Followers

Earnings Data

Report Date
Nov 11, 2025
Before Open (Confirmed)
Period Ending
2025 (Q3)
Consensus EPS Forecast
-0.15
Last Year’s EPS
-0.16
Same Quarter Last Year
Based on 6 Analysts Ratings

Earnings Call Summary

Q2 2025
Earnings Call Date:Aug 05, 2025|
% Change Since:
|
Earnings Call Sentiment|Neutral
The earnings call depicted both strong achievements, particularly with the successful launch of Evolysse and international expansion, and significant challenges, including decreased demand for Jeuveau and a challenging market environment. While there are optimistic signs for the future, such as expected improvements in demand and strategic cost optimizations, the immediate outlook is hindered by current market conditions.
Company Guidance
During Evolus' second-quarter earnings call, the company revised its 2025 revenue guidance to a range of $295 million to $305 million, indicating an 11% to 15% growth over 2024. This adjustment reflects current U.S. market trends and a strategic realignment of their operating model to enhance profitability. Despite reporting a year-over-year revenue decrease for Jeuveau due to a challenging market environment, Evolus remains optimistic, projecting a total net revenue of $700 million by 2028 with non-GAAP operating income margins of 20%. The company also highlighted the successful launch of Evolysse, which generated $9.7 million in its first-quarter revenue, and reported strong performance internationally despite domestic challenges. Evolus plans to achieve positive non-GAAP operating income by Q4 2025 and annual profitability in 2026 by implementing strategic cost optimizations, resulting in more than $25 million in operating expense savings for 2025.
Evolysse Launch Success
Evolysse exceeded internal expectations with $9.7 million in revenue, marking the strongest first-quarter filler launch in over a decade. The product received positive feedback and achieved strong early adoption.
International Expansion
Evolus expanded its global footprint to nine markets, representing over 70% of its international total addressable market, and remains on track to achieve $100 million in international revenue by 2028.
Consumer Loyalty Program Performance
Evolus Rewards redemptions hit a record high of over 224,000, with 65% coming from repeat patients, indicating strong brand loyalty and consumer satisfaction.
Market Share Growth
Jeuveau maintained a 14% market share in the first half of the year, reflecting an increase over the full year 2024 share of 13%, despite market challenges.

Evolus (EOLS) Earnings, Revenues Date & History

The upcoming earnings date is based on a company’s previous reporting, and may be updated when the actual date is announced

EOLS Earnings History

Report Date
Fiscal Quarter
Forecast / EPS
Last Year's EPS
EPS YoY Change
Press Release
Slides
Play Transcript
Nov 11, 2025
2025 (Q3)
-0.15 / -
-0.162
Aug 05, 2025
2025 (Q2)
-0.10 / -0.25
-0.039-533.33% (-0.21)
May 07, 2025
2025 (Q1)
-0.14 / -0.15
-0.083-79.52% (-0.07)
Mar 04, 2025
2024 (Q4)
0.02 / 0.03
-0.124126.61% (+0.16)
Nov 06, 2024
2024 (Q3)
-0.12 / -0.16
-0.1651.82% (<+0.01)
Jul 31, 2024
2024 (Q2)
-0.05 / -0.04
-0.19580.00% (+0.16)
May 07, 2024
2024 (Q1)
-0.15 / -0.08
-0.15145.03% (+0.07)
Mar 07, 2024
2023 (Q4)
-0.07 / -0.12
-0.1379.49% (+0.01)
Nov 07, 2023
2023 (Q3)
-0.22 / -0.17
-0.27840.65% (+0.11)
Aug 02, 2023
2023 (Q2)
-0.25 / -0.20
-0.32640.18% (+0.13)
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat
Missed

EOLS Earnings-Related Price Changes

Report Date
Price 1 Day Before
Price 1 Day After
Percentage Change
Aug 05, 2025
$8.91$6.37-28.51%
May 07, 2025
$11.76$10.09-14.20%
Mar 04, 2025
$14.35$14.17-1.25%
Nov 06, 2024
$16.81$14.29-14.99%
Earnings announcements can affect a stock’s price. This table shows the stock's price the day before and the day after recent earnings reports, including the percentage change.

FAQ

When does Evolus Inc (EOLS) report earnings?
Evolus Inc (EOLS) is schdueled to report earning on Nov 11, 2025, Before Open (Confirmed).
    What is Evolus Inc (EOLS) earnings time?
    Evolus Inc (EOLS) earnings time is at Nov 11, 2025, Before Open (Confirmed).
      Where can I see when companies are reporting earnings?
      You can see which companies are reporting today on our designated earnings calendar.
        What companies are reporting earnings today?
        You can see a list of the companies which are reporting today on TipRanks earnings calendar.
          What is EOLS EPS forecast?
          EOLS EPS forecast for the fiscal quarter 2025 (Q3) is -0.15.
            What am I Missing?
            Make informed decisions based on Top Analysts' activity
            Know what industry insiders are buying
            Get actionable alerts from top Wall Street Analysts
            Find out before anyone else which stock is going to shoot up
            Get powerful stock screeners & detailed portfolio analysis